Although there is no clear evidence of the relationship between KRAS mutations and CRC stage and location, patients with codon 12 mutations were found to be more commonly affected by advanced stage proximal tumors with mucinous histology [110]. The gene discussed is KRAS; the disease is colorectal carcinoma.